Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guci Shangtong patch in lumbar spondylosis
CTR20130949Phase 2Active
- Sponsor
- Hangzhou Tiancheng Pharmaceutical
- Start
- Oct 2013
- Countries
- 1
01
Overview
A Phase 2 trial of Guci Shangtong patch in lumbar spondylosis, sponsored by Hangzhou Tiancheng Pharmaceutical. Started Oct 2013; status: active.
02
Drugs
Guci Shangtong patch
03
Conditions
lumbar spondylosis
Beyond the preview
Go deeper on CTR20130949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130949.